MedPath

A Test of the Balance System in Vestibular Migraine

Not Applicable
Conditions
Vestibular Migraine
Neurological - Other neurological disorders
Registration Number
ACTRN12616000683437
Lead Sponsor
Dr Rebecca KellyCampbell
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
52
Inclusion Criteria

For Vestibular Migraine group:

A.At least five episodes fulfilling criteria C and D
B.A current or past history of Migraine without aura or Migraine with aura
C.Vestibular symptoms of moderate or severe intensity, 3 lasting between 5 minutes and 72 hours
D.At least 50% of episodes are associated with at least one of the following three migrainous features:
1.headache with at least two of the following four characteristics:
a)unilateral location
b)pulsating quality
c)moderate or severe intensity
d)aggravation by routine physical activity
2.photophobia and phonophobia
3.visual aura
E.Not better accounted for by another ICHD-3 diagnosis or by another vestibular disorder.

The only criteria for the healthy controls are the exclusion criteria.

Exclusion Criteria

For Vestibular Migraine

1.conductive hearing loss, determined by either pure tone audiometry or tympanometry.
2.inability to maintain tonic EMG neck activity by raising their head from a supine position
3.inability to maintain eye gaze in the superomedial direction.

For Healthy Controls:

Exclusion criteria for healthy controls:
1.significant history of balance/vertigo problems, or headache/migraine.
2.conductive hearing loss, determined by either pure tone audiometry or tympanometry.
3.inability to maintain tonic EMG neck activity by raising their head from a supine position
4.inability to maintain eye gaze in the superomedial direction.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
cVEMP interpeak amplitude<br>[All data is collected on one day for each participant.];cVEMP latency[All data is collected on one day for each participant.];cVEMP threshold[All data is collected on one day for each participant.]
Secondary Outcome Measures
NameTimeMethod
cVEMP prevalence (Primary)[All data is collected on one day for each participant.];oVEMP n10 amplitude (primary)[All data is collected on one day for each participant.];oVEMP latency (primary)[All data is collected on one day for each participant.];oVEMP threshold[All data is collected on one day for each participant.];oVEMP prevalence[All data is collected on one day for each participant.]
© Copyright 2025. All Rights Reserved by MedPath